← Eichor
Condition: Hiv Infected Individuals Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Hiv Infected Individuals

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Upper Gastrointestinal Endoscopy in HIV-infected Individuals
Phase N/A · 1 location(s) · Centre Hospitalier Universitaire Saint Pierre · NCT07425067
A Long-term Follow-up of the HIV-NAT Cohort
Phase N/A · 1 location(s) · The HIV Netherlands Australia Thailand Research Collaboratio · NCT00411983
Exploratory Study of LP-98 for Injection in ART-Naive HIV-Infected Individuals
Phase 1/Phase 2 · 1 location(s) · Shanxi Kangbao Biological Product Co., Ltd. · NCT07433387
Immunogenicity and Safety of the Yellow Fever Vaccine in HIV Infected Individuals
Phase 4 · 1 location(s) · Oswaldo Cruz Foundation · NCT03132311
The Efficacy and Safety Study of CAR-T Cells for Functional Cure in HIV-1/AIDS Patients
Phase 1 · 1 location(s) · Institute of Hematology & Blood Diseases Hospital, China · NCT06880380
Zoledronic Acid for the Prevention of TDF-sparing ART-induced Bone Mass Density Loss in Treatment-naive HIV Positive Ind
Phase 4 · 3 location(s) · Hadassah Medical Organization · NCT06762730
HIV and Changes in the Gut Microbiome After Changes in Antiretroviral Therapy (ART)
Phase N/A · 1 location(s) · University of Manchester · NCT06100211
Frailty in Older HIV-infected Individuals
Phase N/A · 1 location(s) · Chinese University of Hong Kong · NCT03413683
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.